DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Tab.Labetalol and Tab.Nifedipine for Management of Postpartum Hypertension

Information source: Dow University of Health Sciences
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Postnatal Hypertension

Intervention: Labetalol (Drug); Nifedipine (Drug)

Phase: Phase 3

Status: Not yet recruiting

Sponsored by: Dow University of Health Sciences

Official(s) and/or principal investigator(s):
fariha javed, mbbs, Principal Investigator, Affiliation: Dow University of Health Sciences

Overall contact:
fariha javed, mbbs, Phone: 923009298708, Email: farihajaved207@yahoo.com

Summary

To compare effectiveness of oral labetalol and oral nifedipine for management of postpartum hypertension.

Clinical Details

Official title: Comparison of Oral Labetalol and Oral Nifedipine for Postpartum Hypertension Management

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Blood Pressure less than 140/90 mm of hg

Detailed description: A comparison of oral labetalol and oral nifedipine for management of postpartum hypertension. Which drug is more effective in lowering blood pressures in patient with postpartum hypertension.

Eligibility

Minimum age: 20 Years. Maximum age: 48 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- all women with postpartum hypertension as a continuation of pregnancy induced

hypertension,eclampsia, pre-eclampsia or new onset de-novo postpartum hypertension,of any parity.

- age group between 18-48.

- after informed consent.

Exclusion Criteria:

- all women with chronic hypertension, uncontrolled and un treated medical disorders

will be excluded.

- conditions in which drugs labetalol and nifedipine is contraindicated.

Locations and Contacts

fariha javed, mbbs, Phone: 923009298708, Email: farihajaved207@yahoo.com

Additional Information

managment of hypertension and pre eclampsia

poatpartum hypertension

Starting date: May 2015
Last updated: April 23, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017